Articles with "cmv viremia" as a keyword



Photo by nci from unsplash

Absence of CMV viremia in high-grade glioma patients under low dosage glucocorticoid treatment.

Sign Up to like & get
recommendations!
Published in 2017 at "Neuro-oncology"

DOI: 10.1093/neuonc/nox065

Abstract: Foundation, Aidens Avengers, a Cure from Caleb Society, the Operation Grace White Foundation, Ryans Hope, Wayland Villars DIPG Foundation, American Childhood Cancer Organization, Juliana Rose Donnelly Trust, Sheila Jones & Friends, the Ellie Kavalieros DIPG… read more here.

Keywords: glioma patients; grade glioma; high grade; absence cmv ... See more keywords
Photo by martindorsch from unsplash

Impact of high MELD scores on CMV viremia following liver transplantation

Sign Up to like & get
recommendations!
Published in 2022 at "Transplant Infectious Disease"

DOI: 10.1111/tid.14001

Abstract: Advanced liver disease or cirrhosis is associated with an increased risk of infections; however, the impact of high pretransplant model for end‐stage liver disease (MELD) score on cytomegalovirus (CMV) viremia after liver transplantation is unknown. read more here.

Keywords: liver transplantation; cmv viremia; impact high; high meld ... See more keywords
Photo from wikipedia

NK and CD8 T cell phenotypes predict onset and control of CMV viremia post-kidney transplant.

Sign Up to like & get
recommendations!
Published in 2021 at "JCI insight"

DOI: 10.1172/jci.insight.153175

Abstract: Cytomegalovirus (CMV) causes mostly asymptomatic but lifelong infection. Primary infection or reactivation in immunocompromised individuals can be life-threatening. CMV viremia often occurs in solid organ transplant (SOT) recipients and associates with decreased graft survival and… read more here.

Keywords: cd8 cell; transplant; viremia; post ... See more keywords
Photo by cdc from unsplash

Adoptive T-Cell Therapy with 3rd Party CMV-pp65-Specific CTLs for CMV Viremia and Disease Arising after Allogeneic Hematopoietic Stem Cell Transplant

Sign Up to like & get
recommendations!
Published in 2017 at "Blood"

DOI: 10.1182/blood.v130.suppl_1.747.747

Abstract: Adoptive immunotherapy with transplant donor-derived virus-specific T-cells is effective in the treatment of CMV viremia and disease complicating allogeneic hematopoietic stem cell transplant (HCT), but is not available if the donor is seronegative or unavailable… read more here.

Keywords: cmv; disease; ctls; cell ... See more keywords
Photo by nci from unsplash

QuantiFERON-Cytomegalovirus Assay for Prediction of Cytomegalovirus Viremia in Kidney Transplant Recipients: Study From High Cytomegalovirus Seroprevalence Country

Sign Up to like & get
recommendations!
Published in 2022 at "Frontiers in Cellular and Infection Microbiology"

DOI: 10.3389/fcimb.2022.893232

Abstract: Background Early studies showed the utility of pretransplant QuantiFERON-Cytomegalovirus (QF-CMV) assays for CMV-disease prediction post kidney transplant (KT). However, recent data are conflicting. Methods This prospective cohort study enrolled adult patients undergoing KT between July… read more here.

Keywords: cmv viremia; quantiferon cytomegalovirus; cmv assays; cmv ... See more keywords